CSL (ASX:CSL; USOTC:CSLLY) – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.

Products, services, technology

CSL's dynamic portfolio of lifesaving medicines includes those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology.

Cooperation possibilities

Our partnering approach is to structure deals that leverage the value of our R&D, commercial and manufacturing operations. We partner with industry leaders, academia, governments and scientific organizations to contribute our know-how and technologies to bring innovative medicines to life.

Some insights

    CSL has delivered biotechnology excellence for over a century. Today, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland

You may also be interested in